Table 1.

Eligibility Criteria.

Inclusion Criteria	Exclusion Criteria
ACHD patients of any disease severity	Animal Studies
ACHD patients receiving NOAC for: ● Atrial arrhythmias (Intra-atrial reentrant tachycardia, AF, atrial flutter) ● Primary thromboprophylaxis ● Secondary thromboprophylaxis	Pediatric Population
	ACHD patients with severe thrombocytopenia or recurrent hemorrhagic events.

Abbreviations: ACHD: adults with congenital heart disease; AF: atrial fibrillation.